Takeda Pharmaceutical Co (MEX:TAK N) 3-Year Share Buyback Ratio : -0.30% (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Takeda Pharmaceutical Co's current 3-Year Share Buyback Ratio was -0.30%.

The historical rank and industry rank for Takeda Pharmaceutical Co's 3-Year Share Buyback Ratio or its related term are showing as below:

MEX:TAK N' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -26 Med: -0.1 Max: 3.9
Current: -0.3

During the past 13 years, Takeda Pharmaceutical Co's highest 3-Year Share Buyback Ratio was 3.90%. The lowest was -26.00%. And the median was -0.10%.

MEX:TAK N's 3-Year Share Buyback Ratio is ranked better than
66.72% of 676 companies
in the Drug Manufacturers industry
Industry Median: -2.2 vs MEX:TAK N: -0.30

Competitive Comparison of Takeda Pharmaceutical Co's 3-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co's 3-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Takeda Pharmaceutical Co 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Takeda Pharmaceutical Co (MEX:TAK N) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Takeda Pharmaceutical Co 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (MEX:TAK N) » Definitions » 3-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA 4502:Japan 4502:Japan 4502:Japan 0A87:UK TKDA:Germany TKD:Germany TKD:Germany TKD:Germany TAKP34:Brazil TKD:Austria

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines